126 related articles for article (PubMed ID: 19222491)
1. New and emerging treatments for osteoporosis.
Clarke BL
Clin Endocrinol (Oxf); 2009 Sep; 71(3):309-21. PubMed ID: 19222491
[TBL] [Abstract][Full Text] [Related]
2. Emerging therapies in osteoporosis.
MacDonald BR; Gowen M
Best Pract Res Clin Rheumatol; 2001 Jul; 15(3):483-96. PubMed ID: 11485342
[TBL] [Abstract][Full Text] [Related]
3. Future therapeutic targets in osteoporosis.
Deal C
Curr Opin Rheumatol; 2009 Jul; 21(4):380-5. PubMed ID: 19461517
[TBL] [Abstract][Full Text] [Related]
4. [Anabolic therapy of osteoporosis].
Okopień B; Krysiak R; Labuzek K; Herman ZS
Pol Merkur Lekarski; 2005 Jul; 19(109):118-21. PubMed ID: 16194044
[TBL] [Abstract][Full Text] [Related]
5. Current and emerging therapies for osteoporosis.
Mitchner NA; Harris ST
J Fam Pract; 2009 Jul; 58(7 Suppl Osteoporosis):S45-9. PubMed ID: 19825319
[TBL] [Abstract][Full Text] [Related]
6. [Effect of anabolic steroids on osteoporosis].
Adachi M; Takayanagi R
Clin Calcium; 2008 Oct; 18(10):1451-9. PubMed ID: 18830042
[TBL] [Abstract][Full Text] [Related]
7. Anabolic agents and the bone morphogenetic protein pathway.
Garrett IR
Curr Top Dev Biol; 2007; 78():127-71. PubMed ID: 17338916
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomics of osteoporosis: opportunities and challenges.
Nguyen TV; Eisman JA
J Musculoskelet Neuronal Interact; 2006; 6(1):62-72. PubMed ID: 16675890
[TBL] [Abstract][Full Text] [Related]
9. Clinical findings on the therapeutic action of a long-acting anabolic agent.
Luppino V
Panminerva Med; 1965 Oct; 7(10):392-8. PubMed ID: 5320934
[No Abstract] [Full Text] [Related]
10. Novel targets and therapeutics for bone loss.
Margolis RN; Wimalawansa SJ
Ann N Y Acad Sci; 2006 Apr; 1068():402-9. PubMed ID: 16831939
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics of osteoporosis: future perspectives.
Marini F; Brandi ML
Calcif Tissue Int; 2009 May; 84(5):337-47. PubMed ID: 19271099
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of osteoporosis with an enolic ether of dihydrotestosterone. (Clinical studies)].
Domeniconi S
Chir Organi Mov; 1966; 54(5):409-14. PubMed ID: 5333788
[No Abstract] [Full Text] [Related]
13. [Biological monitoring during treatments of systemic osteoporosis. Therapeutic deductions].
Eisinger J; Laponche AM; Moulard JC; Serratrice G; Recordier AM
Rev Rhum Mal Osteoartic; 1971 Apr; 38(4):265-8. PubMed ID: 5563138
[No Abstract] [Full Text] [Related]
14. [On the osteoporosis therapy with anabolic steroids].
Krüskemper HL
Med Welt; 1965 Jun; 24():1347. PubMed ID: 5828648
[No Abstract] [Full Text] [Related]
15. Quest for the Holy Grail to cure arthritis and osteoporosis: emphasis on bone drug delivery systems.
Arkfeld DG; Rubenstein E
Adv Drug Deliv Rev; 2005 May; 57(7):939-44. PubMed ID: 15876396
[TBL] [Abstract][Full Text] [Related]
16. [Experience with anabolic steroid therapy in osteoporosis].
Müller G
Z Arztl Fortbild (Jena); 1973 Mar; 67(6):277-9. PubMed ID: 4716646
[No Abstract] [Full Text] [Related]
17. [On the therapy of osteoporosis with anabolic steroids].
Krüskemper HL
Verh Dtsch Ges Inn Med; 1965; 71():590-6. PubMed ID: 5877670
[No Abstract] [Full Text] [Related]
18. [Osteoporosis: whom, when and how to treat?].
Stepán J
Cas Lek Cesk; 2009; 148(1):25-33. PubMed ID: 19634279
[TBL] [Abstract][Full Text] [Related]
19. [Effects of anabolic hormones on experimental osteoporosis].
Oizumi C
Nihon Seikeigeka Gakkai Zasshi; 1966 Jun; 40(3):269-83. PubMed ID: 4961034
[No Abstract] [Full Text] [Related]
20. [Physiopathology and therapy of osteoporosis].
Hioco D
Dtsch Med Wochenschr; 1966 Jun; 91(23):1079-83. PubMed ID: 5932566
[No Abstract] [Full Text] [Related]
[Next] [New Search]
